- Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn's disease
-
Kotze PG, Magro DO, Saab B, Saab MP, Pinheiro L, Olandoski , Ayrizono M, Martinez C, Coy CS
- KMID: 2402648
- Intest Res.
- 2018 Jan;16(1):62-68.
- doi: 10.5217/ir.2018.16.1.62
BACKGROUND/AIMS: The use of anti-tumor necrosis factor (anti-TNF) agents seems to reduce surgical rates and delay surgical procedures in prospective trials and population-based studies in the management of Crohn's disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study
-
Kotze PG, Spinelli A, da Silva R, de Barcelos IF, Teixeira F, Saad-Hossne R, de Albuquerque IC, Olandoski , da Silva Kotze LM, Suzuki Y, Yamada A, Takeuchi K, Sacchi M, Yamamoto T
- KMID: 2174479
- Intest Res.
- 2015 Jul;13(3):259-265.
- doi: 10.5217/ir.2015.13.3.259
BACKGROUND/AIMS: Postoperative endoscopic recurrence (PER) occurs in nearly 80% of patients 1 year after ileocecal resection in patients with Crohn's disease (CD). Biological agents were more effective in reducing the... -
- CITED
-
- Close
- SHARE
-
- Close
